Commercialisation of Agricultural Biotechnology Crops in Asia

Moving from Ideas to Useful Products

Date: 5th - 7th May 2008
Venue: Le Meridien, Kuala Lumpur

The National Biotechnology Policy envisions that biotechnology will be the new economic engine for Malaysia. Under the new roadmap for biotechnology, emphasis is now shifted to agricultural, healthcare and industrial biotechnology. These areas have been identified based on Malaysia’s leading position in plant commodities and the abundance of natural resources which could be utilized in the healthcare sector. It is targeted that by 2020, this sector would create 280,000 jobs and make a 5% contribution to Malaysia’s Gross Domestic Product. A significant portfolio of R&D projects is currently being undertaken but much of these will remain only as research results until they are taken to the next stage of development into products.

This 3-day training programme will provide a comprehensive, in-depth understanding of the principles, approach, regulatory requirements, information needs, awareness-building techniques, and stewardship requirements for commercializing a biotechnology seed product for widespread farmer adoption and also an understanding of all aspects of the regulatory requirements for biosafety and food/feed safety and the requisite risk assessments

This training programme is presented by Professor Paul S. Teng who is the Dean for Graduate Programs & Research, National Institute of Education at the Nanyang Technological University, Singapore and Dr. Andrew Powell, the CEO of Asia BioBusiness. For more information click here to download the brochure.